Get started
Author

Yogesh Patel

Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH
2024 · Austin Kulasekararaj, Morag Griffin, et al. · Blood · 31
PDF
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis
2019 · V.S. Salhotra, K.S. Sachdeva, et al. · Indian Journal of Tuberculosis · 31
Awareness and practice about preventive method against mosquito bite in Gujarat
2010 · Niraj Pandit, Yogesh Patel, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 29
Why and where?—Delay in Tuberculosis care cascade: A cross-sectional assessment in two Indian states, Jharkhand, Gujarat
2023 · Sandul Yasobant, Harsh Shah, et al. · Frontiers in Public Health · 26
PDF
Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria
2025 · Austin Kulasekararaj, Robert Brodsky, et al. · Annals of Hematology · 21
PDF
Capacity Building, Knowledge Enhancement, and Consultative Processes for Development of a Digital Tool (Ni-kshay SETU) to Support the Management of Patients with Tuberculosis: Exploratory Qualitative Study
2023 · Harsh Shah, Jay Patel, et al. · Journal of Medical Internet Research · 19
PDF
Exploring private sector perspectives on barriers and facilitators in availing tuberculosis care cascade services: a qualitative study from the Indian state
2024 · Harsh D Shah, Shalu Chaudhary, et al. · BMC Family Practice · 14
PDF
Comparison of Lost Productivity Due to Eculizumab and Ravulizumab Treatments for Paroxysmal Nocturnal Hemoglobinuria in France, Germany, Italy, Russia, Spain, the United Kingdom, and the United States
2019 · Adrian R Levy, Laura Dysart, et al. · Blood · 13
HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?
2016 · Ajay M.V. Kumar, Anil Singarajipura, et al. · Journal of Epidemiology and Global Health · 11
PDF
Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis: Phase 3 Long-Term Data
2023 · Austin Kulasekararaj, Morag Griffin, et al. · Blood · 9
Pb2056: Prevalence of Clinically Significant Extravascular Hemolysis in Stable C5 Inhibitor-treated Patients With Pnh and Its Association With Disease Control, Quality of Life and Treatment Satisfaction
2023 · Austin Kulasekararaj, Jennifer Mellor, et al. · HemaSphere · 9
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens
2020 · K. S. Sachdeva, N. Arora, et al. · The International Journal of Tuberculosis and Lung Disease · 8
Framework for implementing collaborative TB-silicosis activities in India: insights from an expert panel
2024 · Mihir P. Rupani, Pankaj Nimavat, et al. · Archives of Public Health · 6
Predictors for Improvement in Patient-Reported Outcomes: Post-Hoc Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
2021 · Hubert Schrezenmeier, Austin G. Kulasekararaj, et al. · Blood · 6
Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India
2019 · Neeta Mathur, Chakrapani Chatla, et al. · Lung India · 6
Ravulizumab Provides Durable Control of Intravascular Hemolysis and Improves Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Follow-up of Study 301 and Comparisons with Patients of the International PNH Registry
2023 · Austin Kulasekararaj, Hubert Schrezenmeier, et al. · Blood · 5
Assessing the Role of Pradhan Mantri TB Mukt Bharat Abhiyaan in India’s Fight against TB: A National-level Data-based Research Investigation
2025 · Harsh Shah, Jay Patel, et al. · Indian Journal of Community Medicine · 4
Psy15 Comparison of Lost Productivity Due to Eculizumab and Ravulizumab Treatments for Paroxysmal Nocturnal Hemoglobinuria in the United States
2019 · A.R. Levy, I. Tomazos, et al. · Value in Health · 4
P772: Long-term Ravulizumab Treatment in Complement Inhibitor-experienced Patients With Pnh Provides Durable Control of Intravascular Hemolysis With Low Incidence of Major Adverse Vascular Events and Death.
2023 · Austin Kulasekararaj, Robert Brodsky, et al. · HemaSphere · 3
Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020)
2020 · Kuldeep Singh Sachdeva, Malik Parmar, et al. · Expert Review of Respiratory Medicine · 3
Pb2040: Lactate Dehydrogenase Is a Predictor of Thromboembolism, and Thromboembolism Is a Predictor of Death, in Patients With Paroxysmal Nocturnal Hemoglobinuria (pnh): Results From a Korean Pnh Registry
2023 · Jun Ho Jang, Jin Seok Kim, et al. · HemaSphere · 2
QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic setting
2023 · K. S. Sachdeva, A. K. Bhatnagar, et al. · The International Journal of Tuberculosis and Lung Disease · 1
PDF
A Liver-Targeted CIDEB siRNA in Adults with MASLD
2026 · Thomas D. Norton, Jorg Taubel, et al. · New England Journal of Medicine
P-1605. A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN17092, an YTE modified Anti-SARS-COV-2 (COVID-19) Monoclonal Antibody in Adult Healthy Volunteers
2026 · Flonza Isa, Jan de Hoon, et al. · Open Forum Infectious Diseases
Danicopan add-on therapy demonstrates positive efficacy and safety outcomes in advanced age adults with paroxysmal nocturnal hemoglobinuria and clinically significant extravascular hemolysis: A sub-analysis of the phase 3 ALPHA trial
2025 · Austin Kulasekararaj, Morag Griffin, et al. · Blood
Works count: 30
Citation count: 261
H-index: 9
I10-index: 9
Year
Topic
Type